Introduction {#s001}
============

Widespread and long-term use of antibiotics may be responsible for the emergence of antibiotic-resistant strains in several bacterial species.^[@B1]^ Recent surveillance studies have shown that such strains are markedly resistant to the main antibiotic types and have transformed into the multidrug-resistant (MDR) strains that are nonsusceptible to ≥3 antimicrobial categories.^[@B6],[@B7]^

Mobile genetic elements such as plasmids, transposons, and integrons play an important role in increasing antibiotic resistance.^[@B6],[@B8],[@B9]^ Class 1 integrons can capture exogenous gene cassettes, thereby ensuring the expression of the genes within these cassettes; hence, they play important roles in the horizontal dissemination of antibiotic resistance genes among bacteria.^[@B1],[@B10],[@B11]^

Currently, more than 130 different gene cassettes have been found in class 1 integrons, most of which are the antibiotic-resistance gene cassettes encoding proteins with resistance to all main antibiotic classes.^[@B12],[@B13]^ These include the quaternary ammonium-compound family, erythromycin, aminoglycosides, sulfonamides, quinolones, chloramphenicol, fosfomycin, trimethoprim, β-lactamases, and other clinically relevant antibiotics.^[@B8],[@B10],[@B14]^

*Pseudomonas aeruginosa*, an important *Pseudomonas* genus member, is noted for its ability to cause severe hospital-acquired bloodstream infections, pneumonia, surgical-site infections, and urinary tract infections in intensive care units^[@B8],[@B15],[@B16]^ with high morbidity and mortality.^[@B17]^ Studies have shown that the mortality rate for mechanical ventilation complicated by *P. aeruginosa* pneumonia is ∼40%. This pathogen is also the main cause of respiratory tract infections in patients with cystic fibrosis, as well as a common cause of disease aggravation in patients with advanced chronic obstructive pulmonary disease.

Therefore, *P. aeruginosa* attracts attention from medical staff.^[@B8]^ Previously, it was thought that carbapenem antibiotics were the last line of defense against multiple drug-resistant, gram-negative bacterial infections. However, with the inappropriate and overuse of antibiotics, there has been a selection pressure for antibiotic-resistant strains to evolve. *P. aeruginosa* has a multiple drug resistance phenotype, and even harbors carbapenem resistance.^[@B8]^ Many studies have investigated the prevalence of integrons in *P. aeruginosa*, but its drug resistance spectrum is rarely reported. Therefore, comparison of the integrons carried by carbapenem-resistant *P. aeruginosa* (CR-PA) strains with carbapenem-sensitive *P. aeruginosa* (CS-PA) strains and characterizing and comparing the gene cassettes from this bacterium are a worthwhile exercise.^[@B17]^

Therefore, we investigated drug resistance in *P. aeruginosa* isolated from the clinic, the carriage of class I integrons among CR-PA strains and CS-PA strains, and the characteristics of the variable regions of class I integrons from this bacterium.

Materials and Methods {#s002}
=====================

Bacterial strains {#s003}
-----------------

Altogether, 113 *P. aeruginosa* strains were isolated from patients hospitalized in Weifang People\'s Hospital (Weifang, China). These isolates were collected from September to October 2018. We have received and archived written patient consent from all patients included in this study, and the approval by the hospital ethics committee for the use of samples for human patients. Patients needed to have been hospitalized \>3 days to qualify for specimen collection. There were obvious symptoms of infection in each system. Symptoms of tissue infection were redness, necrosis, or exudation. Symptoms of respiratory tract infection were fever, cough, and imaging findings. Examples of systemic symptoms were shivering, fever, as well as increases in levels of leukocytes, erythrocyte sedimentation rate, and C-reactive protein.

All specimens were collected and transported in aseptic containers. For respiratory specimens, the patient had to gargle before coughing-up sputum. After each sputum sample had been sent to the laboratory, the number of white cells was \>25 per low magnification, and the number of squamous cells was \<10 per low magnification, and all were identified by Vitek-2 Compact (BioMérieux, Marcy-l\'Étoile, France). *Escherichia coli* DH5α was from our laboratory. *Proteus mirabilis* 47437 was gifted by the Clinical Laboratory of Zhejiang Province People\'s Hospital (Zhejiang, China).

Antimicrobial susceptibility testing {#s004}
------------------------------------

Several antibiotics were selected as representative drugs. Antimicrobial susceptibility testing on these antibiotics was done using the disk diffusion method according to the Clinical and Laboratory Standards Institute (CLSI) guidelines.^[@B20]^ The antibiotics chosen were amikacin (AK), ceftazidime, ciprofloxacin (CIP), levofloxacin (LEV), cefepime, gentamicin, tobramycin (TOB), imipenem (IPM), aztreonam (ATM), cefoperazone/sulbactam (CSL), piperacillin (PRL), piperacillin/tazobactam (TZP), and meropenem (MEM). Isolates shown to be resistant to IPM or MEM were defined as "CR-PA," and those resistant to three or more drugs class were defined as "MDR-PA." *P. aeruginosa* ATCC 27853 was used as the control for antibiotic resistance.

Polymerase chain reaction assay for screening class 1 integrons {#s005}
---------------------------------------------------------------

All strains were streaked onto Luria Bertani (Oxoid, UK) agar plates and incubated overnight at 37°C. A single clone from each strain was picked and suspended in 50 μL of distilled water. After incubation (100°C water bath, 10 minutes) and centrifugation (13,750*g*, 2 minutes), the supernatant was used as the polymerase chain reaction (PCR) template for screening of class 1 integrons. Primers intF and P~2~R ([Table 1](#tb1){ref-type="table"}), which target the class 1 integron integrase (*intI1*), were used. A blank control (distilled water), a negative control (*E. coli* DH5α), and a positive control (*P. mirabilis* 47437) were included in each run.

###### 

PCR Primers Used in This Study

  Gene     Description                                                     Sequence (5′→3′)       Reference
  -------- --------------------------------------------------------------- ---------------------- -----------
  *intF*   Screening primer for class 1 integrons                          CCAAGCTCTCGGGTAACATC   ^[@B5]^
  *P2R*    Screening primer for class 1 integrons                          GCCCAGCTTCTGTATGGAAC   ^[@B5]^
  *5CS*    Screening primer for the variable region of class 1 integrons   GGCATCCAAGCAGCAAG      ^[@B5]^
  *3CS*    Screening primer for the variable region of class 1 integrons   AAGCAGACTTGACCTGA      ^[@B5]^

Identifying the variable regions of class 1 integrons {#s006}
-----------------------------------------------------

Because boiling method is a rough extraction method, which nucleic acid concentration may decrease over time, this method can be used in the preliminary screening of integron. To ensure the reproducibility and stability of the experimental results, the reagent extraction method should be used in further experiments. Therefore, we adopt the method of extracting DNA by kit to screen the variable region of integron. Total genomic DNA was isolated from the class 1 integron-positive strains using the EZ-10 Spin Column Bacterial Genomic DNA Miniprep Kit (Bio Basic, Canada) according to the supplier\'s instructions. [Table 1](#tb1){ref-type="table"} shows the primers used in this study. Primers 5CS and 3CS were used to amplify the variable regions of the class 1 integrons.

For the PCRs, LA Taq DNA polymerase (TaKaRa Biotechnology, Japan) was used according to the manufacturer\'s instructions. After electrophoresis on a 1% agarose gel, the PCR products were excised and purified according to the manufacturer\'s instructions of the EZ-10 Spin Column Gel Extraction Kit (Bio Basic). All amplicons were sequenced by primer walking, starting with 3CS and 5CS. Nucleotide sequences were analyzed and compared using BLAST software.

Statistical analysis {#s007}
--------------------

The data were analyzed using SSPS v17.0 (IBM, Armonk, NY). Comparisons were considered significant if *p* \< 0.05.

Results {#s008}
=======

Clinical samples and bacterial isolation {#s009}
----------------------------------------

Altogether, 113 *P. aeruginosa* isolates were collected from hospitalized patients. Most specimens were sputum (69.9%; 79/113), followed by aseptic site specimens (21.2%; 24/113), blood (5.3%; 6/113), and urine (3.5%; 4/113). CR-PA and CS-PA were 30 and 83, respectively.

Resistance phenotypes {#s010}
---------------------

[Table 2](#tb2){ref-type="table"} shows the antimicrobial resistance phenotypes of the isolates toward 13 antimicrobial agents. Antimicrobial susceptibility testing revealed that of the 113 isolates expressing phenotypic resistance to the tested antimicrobials, the most common resistance was to CIP (26.55%) followed by IPM (23.89%) and MEM (23%); all other antimicrobials had values of \<20% ([Table 2](#tb2){ref-type="table"}). *P. aeruginosa* multidrug-resistant isolates (resistant to at least three antimicrobial classes) were recovered from the two sets of isolates investigated in our study. Isolates with resistance to all the antimicrobials tested occurred only in the CR-PA isolates. The highest prevalence of resistance in the CR-PA isolates was to IPM (93.33%) followed by MEM (86.67%), LEV (56.67%), and CIP (53.33%); all other antimicrobials had values of \<40%. In the CS-PA isolates, the most common resistance was to LEV (16.87%), followed by CIP (15.66%); all other antimicrobials had values of \<20%. Comparison of drug resistance in the CS-PA and CR-PA groups revealed that, with the exception of GEN and ATM, the other 11 antimicrobial agents differed, and the differences were significant.

###### 

Resistance Phenotypes and Comparison of Carbapenem-Resistant *Pseudomonas aeruginosa* with Carbapenem-Sensitive *P. aeruginos*a

        CR-PA   CS-PA   Total (%)   *p*
  ----- ------- ------- ----------- -------
  AK    23.33   0       7.07        0.000
  ATM   26.67   14.46   17.70       0.222
  CAZ   36.67   3.61    12.39       0.000
  CIP   53.33   15.66   26.55       0.000
  CSL   36.67   6.02    15.04       0.000
  FEP   36.67   0       9.73        0.000
  GEN   16.67   6.02    9.73.       0.079
  IPM   93.33   0       23.89       ---
  LEV   56.67   16.87   27.4        0.000
  MEM   86.67   0       23.0        ---
  PIP   36.67   13.25   19.46       0.006
  TOB   30.00   4.81    12.39       0.001
  TZP   30.00   6.02    12.39       0.001

AK, amikacin; ATM, aztreonam; CAZ, ceftazidime; CIP, ciprofloxacin; CR-PA, carbapenem-resistant *P. aeruginosa*; CSL, cefoperazone/sulbactam; CS-PA, carbapenem-sensitive *P. aeruginosa*; FEP, cefepime; GEN, gentamicin; IPM, imipenem; LEV, levofloxacin; MEM, meropenem; PRL, piperacillin; TOB, tobramycin; TZP, piperacillin/tazobactam.

Resistance patterns {#s011}
-------------------

The strains were divided into two groups based on their carbapenem resistance levels (CR-PA, 30 strains; CS-PA, 83 strains) and the definition rules. The total number of multidrug-resistant *P. aeruginosa* (MDR-PA) isolates in the CS-PA group was 16.87% (14/83), whereas that of CR-PA was 40% (12/30) ([Table 3](#tb3){ref-type="table"}). The CS-PA isolates displayed 23 patterns, the predominant multidrug resistance pattern of which was CIP-LEV (7.23%, 6/83) followed by CIP--LEV-IPM-MEM (3.61%, 3/83). ATM and CIP-LEV-IPM patterns were displayed by two strains. Only one strain exhibited another resistance pattern. Twelve patterns were seen for the CR-PA isolates, and the predominant multidrug resistance pattern was IPM-MEM (23.33%, 7/30), followed by AK-ATM-CAZ-CIP-CSL-FEP-IPM-LEV-MEN-PRL-TOB-TZP (10%, 3/30). Sixty *P. aeruginosa* isolates displayed sensitivity to all 13 antimicrobial agents.

###### 

Antimicrobial Resistance Phenotypes and Molecular Characterization of Gene Cassettes in Class 1 Integrons

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Sample no.                                                                                                                                                                                                                                           Resistance pattern                                               Int   Length      Gene cassettes                 GenBank accession no.
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------- ----- ----------- ------------------------------ -----------------------
  1, 2, 4, 8, 9, 15, 17, 20, 22, 26, 27, 29, 30, 31, 34, 38, 38, 44, 45, 47, 49, 50, 52, 53, 55, 56, 57, 60, 62, 63, 64, 65, 66, 67, 68, 69, 73, 74, 75, 76, 77, 78, 79, 80, 82, 84, 89, 93, 95, 96, 98, 102, 106, 107, 109, 110, 112, 114, 115, 116   Sensitive to all drugs                                           −     −           −                               

  CS-PA                                                                                                                                                                                                                                                                                                                                                                  

   3, 83                                                                                                                                                                                                                                               ATM                                                              −     −           −                               

   117                                                                                                                                                                                                                                                 PRL                                                              −     −           −                               

   25, 51, 92, 94, 99, 105                                                                                                                                                                                                                             CIP, LEV                                                         −     −           −                               

   85                                                                                                                                                                                                                                                  ATM, PRL                                                         −     −           −                               

   13                                                                                                                                                                                                                                                  LEV, PRL                                                         −     −           −                               

   41                                                                                                                                                                                                                                                  ATM, CIP, LEV                                                    −     −           −                               

   100                                                                                                                                                                                                                                                 ATM, CIP, LEV                                                    \+    −           −                               

   43                                                                                                                                                                                                                                                  CAZ, PRL, TZP                                                    −     −           −                               

   5, 88                                                                                                                                                                                                                                               CIP, LEV, IPM                                                    −     −           −                               

   61                                                                                                                                                                                                                                                  CIP, LEV, PRL                                                    −     −           −                               

   104                                                                                                                                                                                                                                                 CIP, LEV, GEN                                                    \+    −           −                               

   35                                                                                                                                                                                                                                                  ATM, CSL, PRL                                                    \+    1.1k        AadA22                         CP041394.1\
                                                                                                                                                                                                                                                                                                                                                                         99.48%

   23                                                                                                                                                                                                                                                  GEN, PRL, TOB, TZP                                               \+    2.1k        *aadB-aac(6′)-1I-pse-1*        *DQ266447.1*\
                                                                                                                                                                                                                                                                                                                                                                         *97.6*

   32                                                                                                                                                                                                                                                  ATM, CSL, PRL, TZP                                               −     −           −                               

   6, 11, 19                                                                                                                                                                                                                                           CIP, LEV, IPM, MEM                                                     −           −                               

   48                                                                                                                                                                                                                                                  ATM, CIP, LEV, MEM                                               −     −           −                               

   16                                                                                                                                                                                                                                                  CSL, LEV, IPM, MEM                                               −     −           −                               

   87                                                                                                                                                                                                                                                  ATM, CIP, GEN, LEV, TOB                                          −     −           −                               

   108                                                                                                                                                                                                                                                 ATM, CAZ, CSL, PRL, TOB                                          −     −           −                               

   18                                                                                                                                                                                                                                                  CAZ, CIP, FEP, GEN, LEV, TOB                                     \+    −           −                               

   111                                                                                                                                                                                                                                                 AK, ATM, CIP, CSL, GEN, TOB                                      \+    3.2k        *dhfr2-aacA4-aadA1-tna*         

   97                                                                                                                                                                                                                                                  ATM, CIP, CSL, GEN, LEV, PRL, TOB                                −     −                                           

   42                                                                                                                                                                                                                                                  ATM, CAZ, CIP, CSL, GEN, LEV, PRL, TOB, TZP                      −     −           −                               

  CR-PA                                                                                                                                                                                                                                                                                                                                                                  

   21                                                                                                                                                                                                                                                  IPM, MEM, LEV                                                    −     −           −                               

   14                                                                                                                                                                                                                                                  IPM, MEM, PRL                                                    −     −           −                               

   7, 10, 12, 40, 59, 81, 113                                                                                                                                                                                                                          IPM, MEM                                                         −     −           −                               

   72                                                                                                                                                                                                                                                  CAZ, IPM, MEM, PRL                                               −     −           −                               

   103                                                                                                                                                                                                                                                 CIP, FEP, LEV, IPM, MEM                                          −     −           −                               

   28                                                                                                                                                                                                                                                  ATM, CAZ, CSL, FEP, IPM, MEM, PRL                                −     −           −                               

   33                                                                                                                                                                                                                                                  ATM, CAZ, CSL, IPM, MEM, PRL, TZP                                −     −           −                               

   54                                                                                                                                                                                                                                                  CIP, CSL, FEP, GEN, IPM, LEV, MEN, PRL, TOB, TZP                 \+    −           −                               

   71                                                                                                                                                                                                                                                  AK, ATM, CAZ, CIP, CSL, FEP, IPM, MEN, PRL, TOB, TZP             \+    2.1k        *aacA4-blaOXA101-aadA5*         

   36, 46, 101                                                                                                                                                                                                                                         AK, ATM, CAZ, CIP, CSL, FEP, IPM, LEV, MEN, PRL, TOB, TZP        \+    2.1k        *aacA4-blaOXA101-aadA5*         

   39, 70                                                                                                                                                                                                                                              AK, CAZ, CIP, CSL, FEP, GEN, IPM, LEV, MEN, PRL, TOB, TZP        \+    2.2k+2.8k   *qnrvc-gcu165-arr2-dfrA22e*\   *KU984332*\
                                                                                                                                                                                                                                                                                                                                          *aacA4-gcu35-blaOXA-1-catB3*   *KU984333*

   24                                                                                                                                                                                                                                                  AK, ATM, CAZ, CIP, CSL, FEP, GEN, IPM, LEV, MEN, PRL, TOB, TZP   \+    2.1k        *aacA4-blaOXA101-aadA5*        *KM111259.1*\
                                                                                                                                                                                                                                                                                                                                                                         *99.35%*
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

+, presence of the PCR product; −, absence of the PCR product.

ATM, aztreonam (30 mg); IPM, imipenem (10 mg).

Prevalence of class 1 integrons and amplification products from the variable regions {#s012}
------------------------------------------------------------------------------------

Class 1 integrons were detected in 14 (12.4%, 14/113) isolates ([Table 3](#tb3){ref-type="table"}), 7.22% (6/83) in the CS-PA isolates and 26.67% (8/30) in the CR-PA isolates. The variable regions of the class 1 integrons were amplified and analyzed successfully for 10 *intI1*-positive isolates, but these regions failed to amplify in four *intI1-*positive isolates. In the remaining 10 *intI1*-positive isolates, only partial variable region sequences were amplified and sequenced.

Six gene cassette arrays were detected ([Table 3](#tb3){ref-type="table"}), the most prevalent of which were *aacA4-blaOXA101-aadA5* (detected in five strains), whereas *qnrvc-gcu165-arr2-dfrA22e*, *aacA4-gcu35-blaOXA-1-catB3*, *aadB-aac(6′)-1I-pse-1*, *dhfr2-aacA4-aadA1-tna*, and AadA22 were detected in 2, 2, 1, 1, and 1 isolates, respectively. *aacA4-blaOXA101-aadA5*, *aacA4-gcu35-blaOXA-1-catB3*, and *qnrvc-gcu165-arr2-dfrA22e* gene cassette arrays were detected in CR-PA at 5/30, 2/30, and 2/30, respectively, whereas *aadB-aac(6′)-1I-pse-1*, *dhfr2-aacA4-aadA1-tna*, and *AadA22* were detected in CS-PA in 1, 1, and 1 isolates, respectively. Strain numbers 39 and 70 both contained two gene cassette arrays (*qnrvc-gcu165-arr2-dfrA22e* and *aacA4-gcu35-blaOXA-1-catB3*).

Seventeen gene cassettes were detected, including *blaOXA-1/101*, *pse-1*, *aacA4*, *aac6-II*, *aadA1/A5//B*, *AadA22*, *arr2*, *catB3*, *dfrA22e*, *dhfr2*, *tna*, *qnrvc*, and *gcu35/165* ([Table 3](#tb3){ref-type="table"}). The most prevalent antibiotic resistance gene cassettes were *aacA4* (7/113), which confers resistance to aminoglycosides, *aadA5* (5/113), which confers resistance to streptomycin and spectinomycin, and *blaOXA-101* (5/113), which confers resistance to β-lactamases. The structural characteristics and translation directions of the variable region gene cassettes are shown in [Fig. 1](#f1){ref-type="fig"}.

![Genetic environment of class 1 integron variable regions. **(A)** Isolate 35. **(B)** Isolate 23. **(C)** Isolates 24, 36, 46, 71, and 101. **(D1, D2)** Isolates 39 and 70. **(E)** Isolate 111.](mdr.2019.0406_figure1){#f1}

Comparison between integron-positive and integron-negative isolates {#s013}
-------------------------------------------------------------------

Of the 14 integron-positive isolates, \>70% were resistant to CIP, LEV, and TOB, and \>50% were resistant to the other drugs. In the integron-negative isolates, only resistance to IPM and MEM was close to 20%, whereas resistance to the other drugs was \<20% or close to 0. Comparison of the drug sensitivity of the two groups revealed that the drug resistance rates for the 13 antimicrobial agents in the integron-positive isolates were higher than those of the integron-negative isolates, and the difference was significant ([Table 4](#tb4){ref-type="table"}).

###### 

Comparison Between Integron-Positive and Integron-Negative Isolates

        int+ (%)   int− (%)   *p*
  ----- ---------- ---------- -------
  AK    50.00      0.00       0.000
  ATM   57.14      12.12      0.000
  CAZ   57.14      6.06       0.000
  CIP   78.57      18.18      0.000
  CSL   64.29      7.07       0.000
  FEP   64.29      2.02       0.000
  GEN   50.00      3.03       0.000
  IPM   57.14      20.20      0.003
  LEV   71.43      21.21      0.000
  MEM   57.14      18.18      0.001
  PIP   64.29      13.13      0.000
  TOB   71.43      3.03       0.000
  TZP   64.29      5.05       0.000

int+: integron-positive isolates; int−: integron negative isolates.

Discussion {#s014}
==========

In recent years, the emergence and spread of MDR bacteria have brought great challenges to the clinical treatment of bacterial infections. *P. aeruginosa*, a clinically important *Pseudomonas* species, causes nosocomial infections worldwide. During transmission of bacterial drug resistance, the movement of genes and other DNA sequences (*e.g.*, drug resistance plasmids, transposons, insertion sequences, and integrons, among others) plays an important role. Increased antibiotic resistance in *P. aeruginosa* isolates can be attributed to their ability to obtain resistance by the movement of genetic elements. Because of the role played by class 1 integrons in the rapid dissemination of multiple genes encoding antibiotic resistance,^[@B6]^ we analyzed the prevalence of class 1 integrons in *P. aeruginosa*.

Altogether, 113 *P. aeruginosa* isolates were collected, primarily from sputum (69.9%; 79/113), aseptic site specimens (21.2%; 24/113), blood (5.3%; 6/113), and urine (3.5%; 4/113).

The isolates from our study were CR-PA and CS-PA types, comprising 30 and 83, respectively. Excluding IPM and MEM, of the 11 other drugs, only GEN did not show a significant difference in resistance. Resistance in the CR-PA group was greater than that of the CS-PA group, and the difference was significant, a finding also shown by Gu B^[@B21]^ and colleagues. This finding suggests that new drug-resistant genes are captured continuously by *P. aeruginosa* under the selection pressure of an antibacterial agent, which enables *P. aeruginosa* to survive if various medicines are administered. In addition, based on the integron carrier, the collected strains were divided into integron-positive and integron-negative groups, from which drug resistance was compared. The results showed more integron-positive groups than integron-negative groups in all 13 commonly used clinical drugs, and the difference was significant. This result is similar to that of other scholars.^[@B5],[@B21]^

Class 1 integrons were detected in 14 (12.4%, 14/113) isolates, a similar finding to other research from China.^[@B5],[@B21]^ However, this result is quite different from those of studies in which the determinants of drug resistance related to integrons were found in the isolates from several *P. aeruginosa* outbreaks.^[@B6],[@B24],[@B25]^ Studies have shown that almost half of all drug-resistant *P. aeruginosa* strains carry integrons.^[@B6],[@B26]^ It has been suggested that the homozygous carriage rate for *P. aeruginosa* in China is lower than that in other countries, and the results of our study are in accordance with data from China.^[@B5],[@B21]^

We detected six gene clusters containing 17 gene cassettes in the variable regions of the isolates. These gene cassettes contain not only aminoglycoside and trimethoprim drug-resistant genes (the antibiotics for which were used commonly in China in the early to mid-20th century) but also genes encoding resistance to β-lactamases, fluoroquinolones, and even carbapenem (the antibiotics for which are used widely at present). Previously, these genes were underdetected or detected mainly in other species, whereas in *P. aeruginosa*, they were relatively rare. Furthermore, a transposition enzyme, genome gene cassettes (*gcu*35/165), and various other integrons were detected in our study, and this was relatively rare in the variable regions of integrons in the past. The specific functions of the integrons in these gene cassettes are obscure and must be studied further.

Novel genes conferring antibiotic resistance, such as *qnrVC6*, have been reported in different species.^[@B6],[@B27]^ *blaOXA-01/101*, which mainly mediates drug resistance in *Acinetobacter baumannii*, also had a high detection rate in our study. In addition, the diversity of gene cassettes carried by class 1 integrons is broadening,^[@B6],[@B30]^ and aad cassettes (which confer resistance to aminoglycosides) were detected herein with a similarly high detection rate as that reported previously. However, gene cassettes encoding resistance to trimethoprim (dfrA) were found less frequently in our study. Previously, it was considered that this gene is highly stable in Enterobacteriaceae-integrated zygotes, with high detection rates in most strains. That the detection rate of dfrA in the present study was low may reflect that *P. aeruginosa* has a strong ability to respond quickly to the selection pressure of antibiotics.^[@B31]^

Although the frequency of isolates resistant to β-lactamases was high, the blaOXA-1 gene cassette was found in only one commensal isolate, suggesting that the genes encoding β-lactamases are mostly located outside of integrons, which was also observed by Mokracka *et al.*^[@B34],[@B35]^ The extended-spectrum β-lactamase resistance genes---blaOXA-1 and blaOXA-101---were also found in the present study. These genes can confer resistance to cefepime and IPM, the most commonly used antibiotics nowadays. However, these gene cassettes were found in only two intI1-positive isolates. Possibly the selection pressure of these antibiotics lacks strength or insufficient time has passed to select for a higher prevalence of these gene cassettes.^[@B5],[@B6],[@B21],[@B31]^

Conclusions {#s015}
===========

Our data suggest that *P. aeruginosa* is found commonly in clinical respiratory tract infections and aseptic site infections, and drug resistance in it has been increasing considerably in recent years. The integron carriage rate of *P. aeruginosa* and the characteristics of the gene cassettes it carries suggest that there are similarities and differences in the genes it carries compared with other species. Stably acquired drug resistance genes are being eliminated in *P. aeruginosa*.

Concurrently, genetic resistance elements against commonly used clinical drugs (*e.g.*, β-lactamases, fluoroquinolones, and even carbapenems), as well as some other gene elements, are newly integrated. The variable regions of the integrons showed that the gene clusters we identified were, in general, large, and there were many gene cassette types, both of which play a very important role in drug resistance in *P. aeruginosa*. The continuous evolution of drug resistance in *P. aeruginosa* brings great challenges to its clinical treatment. Therefore, curbing drug resistance and the spread of *P. aeruginosa* infections are important goals.
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